CVS - Walgreens: Waiting To See If New Medicine Works
2024-05-06 17:06:50 ET
Summary
- Walgreens Boots Alliance is currently trading at a cheap valuation with a non-GAAP Fwd P/E of 5.5x.
- The company is an integrated healthcare and pharmacy retailer with a strong presence in the US, Europe, and Latin America.
- With a new CEO and a plan to adopt 'cost plus' pricing, there is some hope for a turnaround in profitability. However, I prefer to wait to see actual results.
I came across Walgreens Boots Alliance, Inc. ( WBA ) while screening for stocks trading at cheap valuations. With a non-GAAP Fwd P/E of just 5.5x, Walgreens is certainly one of the cheapest large-cap stocks in the market (Figure 1)....
Walgreens: Waiting To See If New Medicine Works